Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Qi Zhou, Kezhu Hou & Zhiqiang Fu. (2022) Transferrin-Modified Mangiferin-Loaded SLNs: Preparation, Characterization, and Application in A549 Lung Cancer Cell. Drug Design, Development and Therapy 16, pages 1767-1778.
Read now
Read now
Nan Lu, Jinhui Liu, Chengjian Ji, Yichun Wang, Zhipeng Wu, Shuning Yuan, Yan Xing & Feiyang Diao. (2021) MiRNA based tumor mutation burden diagnostic and prognostic prediction models for endometrial cancer. Bioengineered 12:1, pages 3603-3620.
Read now
Read now
Articles from other publishers (20)
Yue He, Hongtao Rao, JingJing Wang, Ying Wu, Caiqin Han, Changchun Yan, Hunter Temple, Le Zhang, Wei Chen & Ying Liu. (2023) Perovskite quantum dots modulating upconversion nanomaterials for cancer early detections. Cancer Nanotechnology 14:1.
Crossref
Crossref
Bokun Zheng, Mingcheng Peng, Jun Gong, Changsheng Li, Hongbing Cheng, Yirong Li & Yueting Tang. (2023) Circulating exosomal microRNA-4497 as a potential biomarker for metastasis and prognosis in non-small-cell lung cancer. Experimental Biology and Medicine 248:16, pages 1403-1413.
Crossref
Crossref
Lin Li & Junyu Li. (2023) Correlation of tumor mutational burden with prognosis and immune infiltration in lung adenocarcinoma. Frontiers in Oncology 13.
Crossref
Crossref
Jing Jing Wang, Ying Liu, Zhou Ding, Le Zhang, Caiqin Han, Changchun Yan, Eric Amador, Liqin Yuan, Ying Wu, Chunyuan Song, Ying Liu & Wei Chen. (2022) The exploration of quantum dot-molecular beacon based MoS2 fluorescence probing for myeloma-related Mirnas detection. Bioactive Materials 17, pages 360-368.
Crossref
Crossref
Hao Rong, Jun Peng, Ke Ma, Jiang Zhu & Jin-Tao He. (2022) Ttc39c is a potential target for the treatment of lung cancer. BMC Pulmonary Medicine 22:1.
Crossref
Crossref
Zhou Ding, Yue He, Hongtao Rao, Le Zhang, William Nguyen, Jingjing Wang, Ying Wu, Caiqin Han, Christina Xing, Changchun Yan, Wei Chen & Ying Liu. (2022) Novel Fluorescent Probe Based on Rare-Earth Doped Upconversion Nanomaterials and Its Applications in Early Cancer Detection. Nanomaterials 12:11, pages 1787.
Crossref
Crossref
Fushi Han, Dongdong Huang, Jinqian Meng, Jiapeng Chu, Meng Wang & Shuzhen Chen. (2022) miR‐126‐5p enhances radiosensitivity of lung adenocarcinoma cells by inhibiting EZH2 via the KLF2/BIRC axis. Journal of Cellular and Molecular Medicine 26:9, pages 2529-2542.
Crossref
Crossref
BaoQing Chen, Mihnea P. Dragomir, Chen Yang, Qiaoqiao Li, David Horst & George A. Calin. (2022) Targeting non-coding RNAs to overcome cancer therapy resistance. Signal Transduction and Targeted Therapy 7:1.
Crossref
Crossref
Jun Wang, Peng Chen, Mingyang Su, Guocheng Zhong, Shasha Zhang & Deming Gou. (2022) Integrative Modeling of Multiomics Data for Predicting Tumor Mutation Burden in Patients with Lung Cancer. BioMed Research International 2022, pages 1-14.
Crossref
Crossref
Lijun Xu & Qing Zheng. (2021) Identification and validation of a miRNA-related expression signature for tumor mutational burden in colorectal cancer. World Journal of Surgical Oncology 19:1.
Crossref
Crossref
Hong Feng, Fujun Yang, Lihong Qiao, Kai Zhou, Junfei Wang, Jiao Zhang, Tian Tian, Ying Du & Hong Shangguan. (2021) Prognostic Significance of Gene Signature of Tertiary Lymphoid Structures in Patients With Lung Adenocarcinoma. Frontiers in Oncology 11.
Crossref
Crossref
Xiao-Jv Chi, Jian-Jun Meng, Chun-Yu Lin, Qi-Sheng Su, Yuan-Yuan Qin, Ru-Hua Wei, Dong Lan & Chao Huang. (2021) Mangiferin Inhibits Human Lung Adenocarcinoma by Suppressing MiR-27b and MiR-92a. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-10.
Crossref
Crossref
Huijuan Zhang, Jing Hu, Aina Liu, Huajun Qu, Fenge Jiang, Congcong Wang, Steven Mo & Ping Sun. (2021) An N6-Methyladenosine-Related Gene Set Variation Score as a Prognostic Tool for Lung Adenocarcinoma. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Weijie Xue, Yixiu Wang, Yuwei Xie, Chenyu Yang, Zhiqi Gong, Chunyang Guan, Chuqing Wei, Chengzhan Zhu & Zhaojian Niu. (2021) miRNA-Based Signature Associated With Tumor Mutational Burden in Colon Adenocarcinoma. Frontiers in Oncology 11.
Crossref
Crossref
Yue Zhao, Li Xu, Xinyu Wang, Shuai Niu, Hezhong Chen & ChunGuang Li. (2021) A novel prognostic mRNA/miRNA signature for esophageal cancer and its immune landscape in cancer progression. Molecular Oncology 15:4, pages 1088-1109.
Crossref
Crossref
Dongdong Yang, Jinling Yu, Bing Han, Yue Sun, Steven Mo & Jing Hu. (2021) Long Non-coding RNA Expression Patterns in Stomach Adenocarcinoma Serve as an Indicator of Tumor Mutation Burden and Are Associated With Tumor-Infiltrating Lymphocytes and Microsatellite Instability. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Congkuan Song, Zhiquan Wu, Qingwen Wang, Yujin Wang, Zixin Guo, Sheng Li & Weidong Hu. (2021) A Combined Two-mRNA Signature Associated With PD-L1 and Tumor Mutational Burden for Prognosis of Lung Adenocarcinoma. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Dong-Yan Zhao, Xi-Zhen Sun & Shu-Kun Yao. (2021) Mining The Cancer Genome Atlas database for tumor mutation burden and its clinical implications in gastric cancer. World Journal of Gastrointestinal Oncology 13:1, pages 37-57.
Crossref
Crossref
Zhengtian Li, Lingling Jiang, Rong Zhao, Jun Huang, Wenkang Yang, Zhenpei Wen, Bo Zhang & Gang Du. (2021) MiRNA-based model for predicting the TMB level in colon adenocarcinoma based on a LASSO logistic regression method. Medicine 100:21, pages e26068.
Crossref
Crossref
Sylvie Brassart-Pasco, Véronique Dalstein, Bertrand Brassart, Maxime Dewolf, Christine Clavel & Jean-Baptiste Oudart. (2020) Immunotherapy in non-small-cell lung cancer: from targeted molecules to resistance patterns. Pharmacogenomics 21:10, pages 705-720.
Crossref
Crossref